CardieX

CardieX is a global medical technology company focused on hypertension, cardiovascular diseases, and other vascular health conditions. The company’s ATCOR division is a world leader in medical devices for measuring arterial stiffness and central blood pressure waveforms, based on its unique FDA-approved and patented SphygmoCor® technology. To date, over 4,500 SphygmoCor® systems have been utilized in various clinical trials conducted by major medical institutions, research organizations, and leading pharmaceutical companies worldwide. ATCOR’s technology has been featured in more than 1,600 peer-reviewed studies published in leading medical journals and cited in thousands of references. The company also develops and licenses its Arty™ platform under the ATCOR.X brand, which includes physiological and health analytics for wearable devices. The company’s digital platform, ArtyNet™, is a connected SaaS ecosystem that provides doctors with a comprehensive telemedicine solution for remote patient health management (launched in 2021).